Accès ouvert
2025
article
OpenAlex
Rashelle B. Hayes, Michael C. Fiore, Betsy Rolland, Robert T. Adsit et autres
INTRODUCTION: The COVID-19 pandemic disrupted cancer screening and treatment delivery, but COVID-19's impact on tobacco cessation treatment for cancer patients who smoke has not been widely explored. AIMS AND METHODS: We conducted a sequential cross-sectional analysis of data collected from 34 National …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jennifer E. Bird, Jason S. Chladek, Heather D’Angelo, Mara M. Minion et autres
PURPOSE: In 2017, the National Cancer Institute (NCI) funded the Cancer Center Cessation Initiative (C3I) to implement and expand tobacco treatment programs in routine oncology care. Many C3I programs developed specialty care programs staffed by tobacco treatment specialists (TTSs) to deliver evidence-based …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jennifer E. Bird, Claire VT Nguyen, Sarah D. Hohl, Heather D’Angelo et autres
Background: Cancer patients who receive evidence-based tobacco-dependence treatment are more likely to quit and remain abstinent, but tobacco treatment programs (TTPs) are not consistently offered. In 2017, the U.S. National Cancer Institute, through the Cancer Moonshot, funded the Cancer Center Cessation Initiative …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Sarah D. Hohl, Richard S. Matulewicz, Ramzi George Salloum, Jamie S. Ostroff et autres
PURPOSE: Quitting smoking improves patients' clinical outcomes, yet smoking is not commonly addressed as part of cancer care. The Cancer Center Cessation Initiative (C3I) supports National Cancer Institute-designated cancer centers to integrate tobacco treatment programs (TTPs) into routine cancer care. C3I centers …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Sarah D. Hohl, Kimberly A. Shoenbill, Kathryn L. Taylor, Mara M. Minion et autres
INTRODUCTION: The COVID-19 pandemic disrupted cancer screening and treatment delivery, but COVID-19's impact on tobacco cessation treatment for cancer patients who smoke has not been widely explored. AIMS AND METHODS: We conducted a sequential cross-sectional analysis of data collected from 34 National …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Sarah D. Hohl, Jennifer E. Bird, Claire VT Nguyen, Heather D’Angelo et autres
BACKGROUND: Delivering evidence-based tobacco dependence treatment in oncology settings improves smoking abstinence and cancer outcomes. Leadership engagement/buy-in is critical for implementation success, but few studies have defined buy-in or described how to secure buy-in for tobacco treatment programs (TTPs) in cancer care. …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Heather D’Angelo, Sarah D. Hohl, Betsy Rolland, Robert T. Adsit et autres
Smoking cessation results in improved cancer treatment outcomes. However, the factors associated with successful implementation of cessation programs in cancer care settings are not well understood. This paper presents the reach the reach and effectiveness of cessation programs implemented in NCI-Designated Cancer …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Heather D’Angelo, Monica Webb Hooper, Jessica L. Burris, Betsy Rolland et autres
Background: Ensuring equitable access to smoking cessation services for cancer patients is necessary to avoid increasing disparities in tobacco use and cancer outcomes. In 2017, the Cancer Center Cessation Initiative (C3I) funded National Cancer Institute (NCI)-designated Cancer Centers to integrate evidence-based smoking …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Ramzi George Salloum, Heather D’Angelo, Ryan P. Theis, Betsy Rolland et autres
BACKGROUND: The Cancer Center Cessation Initiative (C3I) was launched in 2017 as a part of the NCI Cancer Moonshot program to assist NCI-designated cancer centers in developing tobacco treatment programs for oncology patients. Participating centers have implemented varied evidence-based programs that fit …
us
(code pays fourni par la source)
Accès ouvert
2021
preprint
OpenAlex
Ramzi George Salloum, Heather M. D’Angelo, Ryan P. Theis, Betsy Rolland et autres
us, gb
(code pays fourni par la source)
Accès ouvert
2021
preprint
OpenAlex
Ramzi George Salloum, Heather D’Angelo, Ryan P. Theis, Betsy Rolland et autres
Abstract Background: The Cancer Center Cessation Initiative (C3I) was launched in 2017 as a part of the NCI Cancer Moonshot program to assist NCI-designated cancer centers in developing tobacco treatment programs for oncology patients. Participating centers have implemented varied evidence-based programs that …
us, gb
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Heather D’Angelo, Alex T. Ramsey, Betsy Rolland, Li-Shiun Chen et autres
Tobacco cessation after cancer diagnosis leads to better patient outcomes. However, tobacco treatment services are frequently unavailable in cancer care settings, and multilevel implementation challenges can impede uptake of new programs. The National Cancer Institute (NCI) dedicated Cancer Moonshot funding through the …
us
(code pays fourni par la source)